IBD treatment plan ‘needs to be a continuous conversation’

Despite progress in treatment for inflammatory bowel disease, patients and providers reported differing expectations as to remission and other aspects of disease control in a recent global survey, as presented in a poster during the 2020 Congress of the European Crohn’s and Colitis Organisation.“For me personally, it was really eye opening to see the differences from a physician perspective and the patient perspective on certain aspects,” Anita Afzali, MD, of The Ohio State University, told Healio Gastroenterology and Liver Disease. “There was a clear disconnect.”Read More

Share on facebook
Share on twitter
Share on linkedin